Key takeaways:
Depression is common in people with multiple sclerosis (MS).
Symptoms of depression and MS often overlap and exacerbate one another.
Treatment options for depression that occurs with MS include therapy, social support, exercise, and medication.
People with multiple sclerosis (MS) are more likely than the general population to have depression. This may be related to the actual disease itself — up to 50% of people with any autoimmune disease have symptoms of depression — but it’s likely more complicated than that.
There’s a lot of overlap between common symptoms of MS and those of mental health problems like depression, making it difficult to tease them out. Here we’ll take a look at the link between depression and MS.
Yes, in a sense. Experts know that depression is a common feature of MS. Research suggests that at least 1 in 3 people with MS has depression. In some people with MS, depressive symptoms might actually show up before neurological symptoms. But symptoms of depression can happen at any point in the course of MS, and they can also fluctuate over time.
Symptoms of depression can include:
Sadness
Irritability
Loss of interest in activities that you normally enjoy
Changes in sleep pattern
Change in appetite
Poor concentration
In addition to depression and neurological problems, people with MS commonly experience the following:
Fatigue
Poor concentration
Sleep disturbances
Chronic pain
Mood changes
Cognitive problems, such as word finding and processing information
MS can have a big impact on daily living for many: One person with MS shares her tips for living your best life with the condition.
MS treatment has changed dramatically over the past few decades: Our experts review common medications available via injection and infusion.
Not a fan of needles? Here’s what you need to know about oral medications (pills) for MS.
These symptoms of MS overlap with those of depression. In fact, there can be so much overlap between symptoms that it’s often difficult to determine what’s causing what.
Regardless of the cause, these symptoms can have a serious effect on quality of life — and they can even make one another worse. For example, higher pain levels are linked to greater fatigue, which is then linked to higher levels of depression in people with MS. Similarly, depression can worsen other symptoms like fatigue and pain.
It’s not exactly clear why depression is more common in people with MS. Experts believe a combination of factors, including genetics, inflammatory processes, changes in the brain, and social factors, can all contribute to mental health problems.
Because depression is common in people with other autoimmune diseases, it might be somehow linked to the disease. Markers of inflammation found in autoimmune diseases have been linked to depression and fatigue. On the other hand, research also suggests that structural changes in the brain could be to blame.
MS causes neurological symptoms that affect people’s mobility and ability to care for themselves. As such, people who are faced with a life-changing diagnosis such as MS commonly experience grief. This deep sadness is a natural response to loss.
Grief may look a bit like depression, but it tends to be short-lived. However, ongoing struggles with stress, uncertainty, and feelings of hopelessness have been linked with depression. So it’s important to be aware of symptoms and how they’re affecting your daily activities.
Treatment for depression in people with MS is often similar to treatment for depression in anyone else. In other words, treatment relies on therapy and medication. While there are currently no specific guidelines for how to best treat depression in MS, experts generally recommend a combination of approaches:
Talk therapy
Medication
Cognitive therapy for those with cognitive problems due to MS
Exercise could be especially important for depression in MS because studies show that it may reduce depressive symptoms. Other helpful strategies are to connect with others with MS, and to learn various coping strategies.
If you have MS and are struggling with symptoms of grief, anxiety, or depression, know that you don’t have to struggle alone. Community resources, whether online or locally, can provide powerful support and information. You can also contact your neurologist to discuss options for therapy and/or medication.
There isn’t a “best” option in terms of medication. Antidepressant medications called selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used to treat depression in MS. Options include common medications, such as:
Other antidepressant medications, such as tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs), might also be recommended. But they are less commonly used because of possible side effects and drug interactions.
The right option for you will likely depend on your symptoms, other medical problems (if any), and current medications.
Yes, MS can cause “cognitive impairment.” This means it can affect things like your attention span, decision-making ability, and short-term memory. This can happen with or without depression, but depression can make these problems worse.
There are several options for support groups online through the National MS Society. If you prefer to meet in person, you can use this tool to find a support group near you. You can also consider asking your neurology healthcare team to point you in the right direction.
Depression is common in people with MS, and its symptoms can overlap with those of MS. If you’ve been diagnosed with MS, it’s easy to focus on your physical symptoms and not your emotional health. But your mental well-being is important. If you have symptoms of depression or anxiety, or you have trouble with attention and memory, know that treatment is available. Be sure to speak with your neurologist and look into community resources for support.
If you need immediate mental health help, contact the National Suicide Prevention Lifeline at 988 or the Crisis Text Line by texting HELLO to 741741. Both are free, confidential, and available 24 hours a day, 7 days a week.
Amtmann, D., et al. (2015). Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis. Rehabilitation Psychology.
Boeschoeten, R. E., et al. (2017). Prevalence of depression and anxiety in multiple sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences.
Byatt, N., et al. (2011). Relationships between multiple sclerosis and depression. The Journal of Neuropsychiatry and Clinical Neurosciences.
Dalgas, U., et al. (2014). The effect of exercise on depressive symptoms in multiple sclerosis based on a meta-analysis and critical review of the literature. European Journal of Neurology.
Feinstein, A. (2011). Multiple sclerosis and depression. Multiple Sclerosis Journal.
Hughes, A. (n.d.). 5 myths about multiple sclerosis and depression. Johns Hopkins Medicine.
Liu, Y., et al. (2018). Depressive syndromes in autoimmune disorders of the nervous system: Prevalence, etiology, and influence. Frontiers in Psychiatry.
Margoni, M., et al. (2023). Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis. Translational Psychiatry.
Mitolo, M., et al. (2015). Cognitive rehabilitation in multiple sclerosis: A systematic review. Journal of the Neurological Sciences.
National Multiple Sclerosis Society. (n.d.). Cognitive changes and multiple sclerosis.
National Multiple Sclerosis Society. (n.d.). Depression and multiple sclerosis.
National Multiple Sclerosis Society. (n.d.). Find support groups and connection programs.
National Multiple Sclerosis Society. (n.d.). Online multiple sclerosis communities.
National Multiple Sclerosis Society. (n.d.). Sleep and multiple sclerosis.
Pérez, L. P., et al. (2015). Treatment of mood disorders in multiple sclerosis. Current Treatment Options in Neurology.
Pryce, C. R., et al. (2017). Depression in autoimmune diseases. Current Topics in Behavioral Neurosciences.
Tarasiuk, J., et al. (2022). Co-occurrence of fatigue and depression in people with multiple sclerosis: A mini-review. Frontiers in Neurology.